MAPT and tauopathy: TRIM16 has also been implicated in the regulation of immune activation and autophagy, making it a potential therapeutic target for tauopathies, which are characterized by intracellular neurofibrillary tangles composed of hyperphosphorylated filamentous tau proteins [67].